The School of Life Sciences (SLS) of Independent University, Bangladesh (IUB) organised a seminar on precision medicine in the IUB Auditorium on the university campus in the capital recently.
The SLS hosted Dr. Nazneen Aziz, President and CEO of Variant Genomics, Inc. for the seminar titled ‘How Precision Medicine Helps Patient Care and Population Health’.
The seminar focused on the scientific, economic, and social aspects of precision medicine, and provided an update on the current state of genomics technology and its use in precision medicine.
Differences between individuals at the level of the genome can influence their susceptibility to various diseases, as well as affect how they respond to many types of drugs.
As genomic data becomes cheaper and easier to acquire, it is increasingly feasible to examine patients’ genomes while assessing treatment options, paving the way for personalised medicine.
Prof. Rita Yusuf, Dean, School of Life Sciences, IUB welcomed Dr. Aziz, and provided a brief background of her illustrious academic pedigree and achievements in both science and industry.
Prof. Yusuf also provided a backdrop for the talk by illustrating the power and promise of personalised medicine through patient success stories, says a media release.
Prof. M. Omar Rahman, Vice Chancellor, IUB, in his closing address, expounded on the potential of precision medicine to revolutionise healthcare by replacing the current one-size-fits-all approach for the vast majority of drugs.
Ms. Afreen Zaman Khan, Lecturer of Biochemistry, hosted the Seminar.
Members of the Board of Trustees, faculty, and administration were present at the seminar, which was followed by a stimulating and dynamic question and answer session.
